tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Salim Syed, 137 are a BUY (77.84%), 39 are a HOLD (22.16%).
Analyst Salim Syed, currently employed at MIZUHO, carries an average stock price target met ratio of 62.23% that have a potential upside of 45.36% achieved within 272 days.
Salim Syed’s has documented 338 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 18-Mar-2026.
Analyst best performing recommendations are on NKTX (NKARTA ).
The best stock recommendation documented was for NKTX (NKARTA ) at 11/16/2023. The price target of $9 was fulfilled within 53 days with a profit of $6.64 (281.36%) receiving and performance score of 53.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-May-2020
$185
$-162.8 (-46.81%)
1 months 3 days ago
(20-Feb-2026)
5/6 (83.33%)
$-194.73 (-51.28%)
755
Hold Since 07-Aug-2024
$375
$27.2 (7.82%)
$325
1 months 4 days ago
(19-Feb-2026)
11/12 (91.67%)
$-4.73 (-1.25%)
320
Buy Since 02-Jan-2025
$432
$84.2 (24.21%)
$381
1 months 4 days ago
(19-Feb-2026)
7/8 (87.5%)
$52.27 (13.77%)
120
Buy Since 06-Feb-2026
$400
$52.2 (15.01%)
$270
1 months 17 days ago
(06-Feb-2026)
1/2 (50%)
$18.32 (4.80%)
330
Hold Since 20-May-2025
$347
$-0.8 (-0.23%)
$288
1 months 17 days ago
(06-Feb-2026)
1/2 (50%)
$-34.68 (-9.09%)
23
Which stock is Salim Syed is most bullish on?
Which stock is Salim Syed is most reserved on?
What Year was the first public recommendation made by Salim Syed?
